Cargando…
Digital Health Interventions by Clinical Pharmacists: A Systematic Review
Integrating digital interventions in healthcare has gained increasing popularity among clinical pharmacists (CPs) due to advances in technology. The purpose of this study was to systematically review CP-led digital interventions to improve patients’ health-related clinical outcomes. PubMed and the C...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744767/ https://www.ncbi.nlm.nih.gov/pubmed/35010791 http://dx.doi.org/10.3390/ijerph19010532 |
_version_ | 1784630187420286976 |
---|---|
author | Park, Taehwan Muzumdar, Jagannath Kim, Hyemin |
author_facet | Park, Taehwan Muzumdar, Jagannath Kim, Hyemin |
author_sort | Park, Taehwan |
collection | PubMed |
description | Integrating digital interventions in healthcare has gained increasing popularity among clinical pharmacists (CPs) due to advances in technology. The purpose of this study was to systematically review CP-led digital interventions to improve patients’ health-related clinical outcomes. PubMed and the Cochrane Database were searched to select studies that had conducted a randomized controlled trial to evaluate clinical outcomes in adults following a CP-led digital intervention for the period from January 2005 to August 2021. A total of 19 studies were included in our analysis. In these 19 studies, the most commonly used digital intervention by CPs was telephone use (n = 15), followed by a web-based tool (n = 2) and a mobile app (n = 2). These interventions were provided to serve a wide range of purposes in patients’ outcomes: change in lab values (e.g., blood pressure, HbA1c) (n = 23), reduction in health service use (n = 8), enhancing adherence (n = 6), improvement in drug-related outcomes (n = 6), increase in survival (n = 3), and reduction in health-related risk (e.g., CVD risk) (n = 2). Although the impacts of telephone-based interventions on patients’ outcomes were decidedly mixed, web-based interventions and mobile apps exerted generally positive influences. To date, little research has investigated the cost-effectiveness of digital interventions. Future studies are warranted. |
format | Online Article Text |
id | pubmed-8744767 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87447672022-01-11 Digital Health Interventions by Clinical Pharmacists: A Systematic Review Park, Taehwan Muzumdar, Jagannath Kim, Hyemin Int J Environ Res Public Health Review Integrating digital interventions in healthcare has gained increasing popularity among clinical pharmacists (CPs) due to advances in technology. The purpose of this study was to systematically review CP-led digital interventions to improve patients’ health-related clinical outcomes. PubMed and the Cochrane Database were searched to select studies that had conducted a randomized controlled trial to evaluate clinical outcomes in adults following a CP-led digital intervention for the period from January 2005 to August 2021. A total of 19 studies were included in our analysis. In these 19 studies, the most commonly used digital intervention by CPs was telephone use (n = 15), followed by a web-based tool (n = 2) and a mobile app (n = 2). These interventions were provided to serve a wide range of purposes in patients’ outcomes: change in lab values (e.g., blood pressure, HbA1c) (n = 23), reduction in health service use (n = 8), enhancing adherence (n = 6), improvement in drug-related outcomes (n = 6), increase in survival (n = 3), and reduction in health-related risk (e.g., CVD risk) (n = 2). Although the impacts of telephone-based interventions on patients’ outcomes were decidedly mixed, web-based interventions and mobile apps exerted generally positive influences. To date, little research has investigated the cost-effectiveness of digital interventions. Future studies are warranted. MDPI 2022-01-04 /pmc/articles/PMC8744767/ /pubmed/35010791 http://dx.doi.org/10.3390/ijerph19010532 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Park, Taehwan Muzumdar, Jagannath Kim, Hyemin Digital Health Interventions by Clinical Pharmacists: A Systematic Review |
title | Digital Health Interventions by Clinical Pharmacists: A Systematic Review |
title_full | Digital Health Interventions by Clinical Pharmacists: A Systematic Review |
title_fullStr | Digital Health Interventions by Clinical Pharmacists: A Systematic Review |
title_full_unstemmed | Digital Health Interventions by Clinical Pharmacists: A Systematic Review |
title_short | Digital Health Interventions by Clinical Pharmacists: A Systematic Review |
title_sort | digital health interventions by clinical pharmacists: a systematic review |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744767/ https://www.ncbi.nlm.nih.gov/pubmed/35010791 http://dx.doi.org/10.3390/ijerph19010532 |
work_keys_str_mv | AT parktaehwan digitalhealthinterventionsbyclinicalpharmacistsasystematicreview AT muzumdarjagannath digitalhealthinterventionsbyclinicalpharmacistsasystematicreview AT kimhyemin digitalhealthinterventionsbyclinicalpharmacistsasystematicreview |